- Home
- NEXT vs SLNO Comparison
NEXT vs SLNO Comparison
Compare NEXT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEXT | SLNO |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NEXT | SLNO |
|---|---|---|
| Price | $7.73 | $53.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $8.00 | ★ $83.00 |
| AVG Volume (30 Days) | ★ 2.3M | 1.4M |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $1,450,788.00 |
| Revenue This Year | N/A | $150.46 |
| Revenue Next Year | N/A | $50.37 |
| P/E Ratio | ★ N/A | $89.83 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $4.75 | $29.43 |
| 52 Week High | $12.12 | $89.12 |
Technical Indicators
Market Signals| Indicator | NEXT | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 77.32 |
| Support Level | $6.53 | $48.91 |
| Resistance Level | $8.93 | $55.47 |
| Average True Range (ATR) | 0.40 | 0.05 |
| MACD | -0.08 | -0.52 |
| Stochastic Oscillator | 9.58 | 100.00 |
Price Performance
Historical ComparisonAbout NEXT NextDecade Corporation
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.